Semaglutide
US$ 27.34
glp-1 clinical trials Obesity GLP-1 Medications for Weight Loss:
Description
J Alzheimers Dis 101(s1): S317S343
Nauck et al., 2020): Compounds based on the lizard-derived exendin-4 peptide and compounds based on the human GLP-1 peptide
Theyre typically mild to moderate in severity and usually disappear over time
doi:10.1038/nm.3761 43
The exciting beyond obesity frontier for GLP-1 drugs is their potential to treat conditions where inflammation, or other non-obesity factors, are the primary cause
